Brief: OpRegen Data Continues To Show Improvements In Patients - Lineage Cell Therapeutics
03/05/2021 13:52
May 3 (Reuters) - Lineage Cell Therapeutics Inc LCTX.A :
* OPREGEN CLINICAL DATA CONTINUES TO DEMONSTRATE
IMPROVEMENTS IN
PATIENTS WITH DRY AMD WITH GEOGRAPHIC ATROPHY
Source text for Eikon: ID:nBw81GgjGa
Further company coverage: LCTX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million